1337523-99-5

Basic information

• Product Name: 6-BroMo-1,2,3,4-tetrahydronaphthalen-1-aMine
• Synonyms: 6-BroMo-1,2,3,4-tetrahydronaphthalen-1-aMine;6-BROMO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE-HCL;6-Bromo-1,2,3,4-tetrahydro-naphthalen-1-ylamine
• CAS NO: 1337523-99-5
• Molecular Formula: C10H12BrN
• Molecular Weight: 226.11298
• EINECS: -0
• Mol File: 1337523-99-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 300.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.413±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 9.19±0.20(Predicted)
• CAS DataBase Reference: 6-BroMo-1,2,3,4-tetrahydronaphthalen-1-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BroMo-1,2,3,4-tetrahydronaphthalen-1-aMine(1337523-99-5)
• EPA Substance Registry System: 6-BroMo-1,2,3,4-tetrahydronaphthalen-1-aMine(1337523-99-5)

Safety Data

• Hazardous Substances Data: 1337523-99-5(Hazardous Substances Data)

Usage

General Description

6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine, also known as 6-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine, is a chemical compound with the molecular formula C10H12BrN. It is a derivative of 1,2,3,4-tetrahydronaphthalene and contains a bromine atom and an amine group. 6-BroMo-1,2,3,4-tetrahydronaphthalen-1-aMine is used in the synthesis of various pharmaceuticals and organic compounds. It has potential applications in drug development and medicinal chemistry due to its unique chemical structure and properties. Additionally, it may be used as a research reagent in chemical and biological experiments.

Upstream product

• 228256-58-4 6-bromo-1,2,3,4-tetrahydronaphthalen-1-ol 
• 66361-67-9 6-bromo-3,4-dihydro-2H-naphthalen-1-one 

Relevant articles and documents

PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME

The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX) / histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES

The invention provides novel compounds having the general Formula (I), wherein R1, R2, R3, R4 R5, R6, R7, R8 R9, R10, R11, R12, A1, A2 and n are as described herein, compositions including the compounds and methods of using the compounds.